1h Free Analyst Time
The tetanus toxoid vaccine market is forecasted to grow by USD 1.33 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the tetanus toxoid vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by licensing agreements, rising cases of tetanus, diphtheria, and pertussis, and increasing government initiatives regarding vaccination and immunization.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The tetanus toxoid vaccine market is segmented as below:
By Age Group
- Neonatals
- Adults
By Drug Class
- Monovalent tetanus toxoid
- Combination
By End-user
- Hospitals
- Specialty clinics
- Public health agencies
- Ambulatory care centers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the tetanus toxoid vaccine market covers the following areas:
- Tetanus Toxoid Vaccine Market sizing
- Tetanus Toxoid Vaccine Market forecast
- Tetanus Toxoid Vaccine Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Age Group
9 Market Segmentation by Drug Class
10 Market Segmentation by End-user
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global tetanus toxoid vaccine market: Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Shenzhen Kangtai Biological Products Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is new product launches."
According to the report, one of the major drivers for this market is the licensing agreements.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Actiza Pharmaceutical Pvt. Ltd.
- AJ Vaccines AS
- Amson Vaccines and Pharma Pvt Ltd.
- Avalon Pharma Pvt. Ltd.
- Bharat Biotech Ltd.
- CSL Ltd.
- Dano Vaccines and Biologicals Pvt. Ltd.
- Emergent BioSolutions Inc.
- GlaxoSmithKline Plc
- Incepta Vaccine Ltd.
- Meiji Holdings Co. Ltd.
- Merck and Co. Inc.
- Microgen
- Panacea Biotec Ltd.
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- Shenzhen Kangtai Biological Products Co. Ltd.
